ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 355 out of 972

$487K Total Retail Price of All Prescriptions

Rank: 335 out of 972

565 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 429 385 1 2
AMLODIPINE BESYLATE 385 377 2 4
ATORVASTATIN CALCIUM 384 384 3 11
LEVOTHYROXINE SODIUM 361 349 4 3
HYDROCHLOROTHIAZIDE 306 284 5 10
LISINOPRIL 241 227 6 1
ZOLPIDEM TARTRATE 209 190 7 23
OMEPRAZOLE 205 205 8 5
LOSARTAN POTASSIUM 199 192 9 17
SERTRALINE HCL 191 180 10 25
METOPROLOL SUCCINATE 170 163 11 16
HYDROCODONE-ACETAMINOPHEN 170 149 S3 11 6
FUROSEMIDE 144 141 13 7
NEXIUM 142 135 14 30
SYNTHROID 139 136 15 51
WARFARIN SODIUM 132 123 16 12
METOPROLOL TARTRATE 131 115 17 9
POTASSIUM CHLORIDE 121 121 18 13
ATENOLOL 121 118 18 18
TRIAMTERENE-HCTZ 120 120 20 39
CRESTOR 117 109 21 33
AZITHROMYCIN 112 105 22 42
RAMIPRIL 97 93 23 101
ESCITALOPRAM OXALATE 86 86 24 65
DIOVAN 86 86 24 48
LOSARTAN-HYDROCHLOROTHIAZIDE 85 83 26 61
PRAVASTATIN SODIUM 84 80 27 20
PANTOPRAZOLE SODIUM 84 84 27 41
LIPITOR 75 75 29 90
ALLOPURINOL 74 74 30 28
GABAPENTIN 72 62 31 14
CELEBREX 69 69 32 85
CARVEDILOL 67 67 33 21
CYCLOBENZAPRINE HCL 66 55 R 34 53
DILTIAZEM 24HR ER 62 62 35 207
DIOVAN HCT 60 57 36 122
TRAMADOL HCL 57 57 37 15
ALENDRONATE SODIUM 57 57 37 27
KLOR-CON M20 56 55 39 78
MELOXICAM 55 51 40 36
METFORMIN HCL 54 54 41 8
CIPROFLOXACIN HCL 53 50 42 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.